Comparing drug-coated balloon angioplasty versus drug-eluting stents for new coronary artery blockages
Official title: Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions
Run by Chonnam National University Hospital · NCT06954714 · Data updated 2026-11-12
This study will test whether drug-coated balloon angioplasty works as well as drug-eluting stents for adults with new coronary artery narrowings in vessels at least 3.0 mm wide.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 256 (estimated) |
| Sponsor | Chonnam National University Hospital Academic / other |
| Locations | 8 sites (Busan and 7 other locations) |
| Status | Recruiting |
| Started | August 18, 2025 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT06954714 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 19 or older with at least one de novo coronary lesion causing >50% diameter stenosis (or FFR ≤0.80) in a vessel ≥3.0 mm who can give informed consent.
✕Probably not a fit
Patients with left main disease, in-stent restenosis, target lesions in bypass grafts, true bifurcation lesions requiring upfront two-stent techniques, known intolerance to antiplatelet therapy, cardiogenic shock, or life expectancy under one year are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with de novo coronary artery stenosis in vessels ≥3.0 mm will receive either drug-coated balloon angioplasty or drug-eluting stent implantation, and artery changes will be measured using intravascular ultrasound (IVUS). The primary comparison is late-lumen loss (LLL) between the two approaches. The trial focuses on non-complex lesions eligible for percutaneous revascularization and records imaging and clinical outcomes over follow-up. The design compares a no-metal approach (DCB) that may allow shorter dual antiplatelet therapy against the current standard of a permanent metallic DES scaffold.
Why it matters
Potential benefit: If successful, drug-coated balloons could open arteries without leaving permanent metal behind and may allow shorter dual antiplatelet therapy, potentially lowering long-term stent-related risks.
How similar studies have gone: Prior randomized trials and meta-analyses support DCB use for in-stent restenosis and small-vessel de novo lesions, but results for larger or general de novo lesions have been mixed and non-inferiority to DES has not been consistently demonstrated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria 1. Subject must be at least 19 years of age 2. Subject who is able to understand risks, benefits and treatment alternatives and sign informed consent voluntarily 3. Patients with at least one lesion with greater than 50% diameter stenosis or fractional flow reserve ≤0.80 requiring revascularization in de-novo coronary artery of reference vessel size ≥3.0 mm Exclusion Criteria 1. Patients unable to provide consent 2. Patients with known intolerance to aspirin, P2Y12 inhibitors, or components of drug-eluting stents 3. Patients with angiographic findings of 1) Left main coronary artery disease 2) In-stent restenosis is the cause of target lesion 3) Target lesion in bypass graft 4) True bifurcation lesion that requires upfront 2-stenting 4. Patients who have non-cardiac co-morbid conditions with life expectancy \<1 year 5. Patients who may result in protocol non-compliance (site investigator's medical judgment) 6. Patients with cardiogenic shock or cardiac arrest 7. Patients with severe left ventricular systolic dysfunction (ejection fraction \<30%) 8. Patients with severe valvular heart disease requiring open heart surgery 9. Pregnant or lactating women
Where it's running
-
Chonnam National University
Gwangju, South Korea Recruiting -
Kosin University Gospel Hospital
Busan, South Korea Not yet recruiting -
Keimyung University Dongsan Hospital
Daegu, South Korea Not yet recruiting -
Jeonbuk National University Hospital
Jeonju, South Korea Not yet recruiting -
Samsung Medical Center
Seoul, South Korea Not yet recruiting -
Ewha Womans University Mokdong Hospital
Seoul, South Korea Not yet recruiting
Show 2 more locations
-
Korea University Guro Hospital
Seoul, South Korea Not yet recruiting -
Ulsan University Hospital
Ulsan, South Korea Not yet recruiting
Study contacts
- Study coordinator: Seung Hun Lee, MD, PhD
- Email: lsh8602@naver.com
- Phone: +82-62-220-6246
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
-
Gastric Ultrasound Before CABG to See if Heart Function Changes Stomach Contents
This study checks whether people with weaker heart function before elective CABG have different stomach contents seen on ultrasound.
-
Can preoperative photon-counting CT help predict heart recovery after bypass surgery?
This observational study tests whether a preoperative photon-counting CT can help predict heart function 3 months after coronary bypass surgery in adults with coronary artery disease.
-
Real-World Drug-Coated Balloon Angioplasty in Coronary Artery Disease
This registry tests how drug-coated balloons perform in everyday clinical practice for adults with coronary artery disease undergoing PCI.
-
Predicting vasopressor needs after anesthesia in elective on-pump CABG using dynamic arterial elastance
This study tests whether EaDyn measured after induction can help predict which patients will need vasopressors during elective on-pump CABG.
-
Intraoperative Pulse Pressure Variation and Postoperative Lactate Clearance in CABG Patients
This study tests whether the amount a patient’s pulse pressure varies during surgery relates to how quickly lactate levels drop after CABG.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.